TY - JOUR
T1 - USP15 negatively regulates Nrf2 through Deubiquitination of Keap1
AU - Villeneuve, Nicole F.
AU - Tian, Wang
AU - Wu, Tongde
AU - Sun, Zheng
AU - Lau, Alexandria
AU - Chapman, Eli
AU - Fang, Deyu
AU - Zhang, Donna D.
N1 - Funding Information:
We would like to thank Dr. Wolfgang Dubiel for his generous contribution of the USP15 constructs. This work was supported by the following grants: NIEHS 2R01 ES015010 and NCI R01 CA154377 to D.D.Z.; ES007091 and ES016652 to N.F.V.; and P30ES006694.
PY - 2013/7/11
Y1 - 2013/7/11
N2 - Nrf2 is a master regulator of the antioxidant response. Under basal conditions, Nrf2 is polyubiquitinated by the Keap1-Cul3 E3 ligase and degraded by the 26S proteasome. In response to Nrf2 inducers there is a switch in polyubiquitination from Nrf2 to Keap1. Currently, regulation of the Nrf2-Keap1 pathway by ubiquitination is largely understood. However, the mechanism responsible for removal of ubiquitin conjugated to Nrf2 or Keap1 remains unknown. Here we report that the deubiquitinating enzyme, USP15, specifically deubiquitinates Keap1, which suppresses the Nrf2 pathway. We demonstrated that deubiquitinated Keap1 incorporates into the Keap1-Cul3-E3 ligase complex more efficiently, enhancing the complex stability and enzymatic activity. Consequently, there is an increase in Nrf2 protein degradation and a reduction in Nrf2 target gene expression. Furthermore, USP15-siRNA enhances chemoresistance of cells through upregulation of Nrf2. These findings further our understanding of how the Nrf2-Keap1 pathway is regulated, which is imperative in targeting this pathway for chemoprevention or chemotherapy.
AB - Nrf2 is a master regulator of the antioxidant response. Under basal conditions, Nrf2 is polyubiquitinated by the Keap1-Cul3 E3 ligase and degraded by the 26S proteasome. In response to Nrf2 inducers there is a switch in polyubiquitination from Nrf2 to Keap1. Currently, regulation of the Nrf2-Keap1 pathway by ubiquitination is largely understood. However, the mechanism responsible for removal of ubiquitin conjugated to Nrf2 or Keap1 remains unknown. Here we report that the deubiquitinating enzyme, USP15, specifically deubiquitinates Keap1, which suppresses the Nrf2 pathway. We demonstrated that deubiquitinated Keap1 incorporates into the Keap1-Cul3-E3 ligase complex more efficiently, enhancing the complex stability and enzymatic activity. Consequently, there is an increase in Nrf2 protein degradation and a reduction in Nrf2 target gene expression. Furthermore, USP15-siRNA enhances chemoresistance of cells through upregulation of Nrf2. These findings further our understanding of how the Nrf2-Keap1 pathway is regulated, which is imperative in targeting this pathway for chemoprevention or chemotherapy.
UR - http://www.scopus.com/inward/record.url?scp=84891686345&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84891686345&partnerID=8YFLogxK
U2 - 10.1016/j.molcel.2013.04.022
DO - 10.1016/j.molcel.2013.04.022
M3 - Article
C2 - 23727018
AN - SCOPUS:84891686345
SN - 1097-2765
VL - 51
SP - 68
EP - 79
JO - Molecular Cell
JF - Molecular Cell
IS - 1
ER -